Zoekresultaten - 3 results
Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
Publication Type: Peer reviewed scientific article Authors: M. Arbyn; Snijders, Peter J F; Meijer, C.J.L.M.; Berkhof, J; Cuschieri, K.; Kocjan, B.J.; Poljak, M Source: Clinical Microbiology and ...
Clinical evaluation of a GP5+/6+-based luminex assay having full high-risk human papillomavirus genotyping capability and an internal control.
Oligonucleotide Probes Papillomaviridae Papillomavirus Infections Reference Standards Sensitivity and Specificity Young adult Abstract: The LMNX genotyping kit HPV GP (LMNX) is based on the clinically validated GP5 ...
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Keywords: clinical efficacy immunogenicity prophylactic HPV vaccines Abstract: This is the protocol for a review and there is no abstract. The objectives are as follows: To evaluate the immunogenicity, ...